We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MCY:NZXMercury NZ Ltd. Analysis

Data as of 2026-08-20 - not real-time

$104.31

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

Mercury General Corporation is priced at $104.31 and its moving averages line up in bullish order, the shorter sitting above the longer. It has lost 5.3% over the past 30 days. With RSI at 43.6 the momentum picture is neutral, alongside a bearish MACD signal. Recent trading has carved out support near $100.75 and resistance around $112.00.
Multiples put this in undervalued territory: 6.3 times earnings against the sector's 16.8. Analyst price targets sit 15.0% above the current price. Revenue is growing at 13.8% on a 14.8% profit margin. The 1.22% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 3 — low. With 30-day volatility of 24.5%, a beta of 0.06 and a maximum drawdown of 12.9%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 8/10.

Top Market Events

Mercury General MCY delivered earnings and revenue surprises of +95.What Happened? Shares of auto insurance provider Mercury General NYSE:MCY jumped 1.6% in the afternoon session after...Mercury General Corporation NYSE: MCY reported today that after the markets close on Tuesday, August 4, 2026, the...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 95.46
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 6.3 versus sector average of 16.8
  • Trading above the 200-day average of 95.46

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • P/E of 6.3 versus sector average of 16.8
  • Analyst targets imply +15.0% versus the current price
  • Revenue growth of +13.8%

Key Metrics & Analysis

Financial Health

Revenue Growth13.80%
Profit Margin14.78%
P/E Ratio6.3
ROE38.99%
ROA7.57%
Debt/Equity33.92
P/B Ratio2.0
Op. Cash Flow$1.3B
Free Cash Flow$1.1B
Industry P/E16.8

Technical Analysis

TrendBullish
RSI43.6
Support$100.75
Resistance$112.00
MA 20$106.94
MA 50$106.26
MA 200$95.46
MACDBearish
VolumeDecreasing
Fear & Greed Index94.36

Valuation

Fair Value$487.90
Target Price$120.00
Upside/Downside15.04%
GradeUndervalued
TypeBlend
Dividend Yield1.22%

Risk Assessment

Beta0.06
Volatility24.50%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.